Target
O6-methylguanine-DNA methyltransferase (MGMT)
1 product
3 abstracts
Abstract
Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.Org: Berry Consultants, LLC, Global Coalition for Adaptive Research, Hunstman Cancer Institute at the University of Utah, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA,
Product
TMZAbstract
Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Cleveland Clinic Taussig Cancer Instititute, Cleveland Clinic Foundation, Cleveland Clinic Brunswick Urgent Care,
Abstract
Real world data about stupp platform in the treatment of glioblastoma in a single center of Colombia.Org: ICCAL Hospital Universitario Fundación Santa Fe de Bogotá, Fundación Santa Fe de Bogota, ICCAL fundacion Santa Fe de Bogota,